These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16734902)

  • 1. Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa.
    Filopon D; Mérieau A; Bernot G; Comet JP; Leberre R; Guery B; Polack B; Guespin-Michel J
    BMC Bioinformatics; 2006 May; 7():272. PubMed ID: 16734902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.
    Augustin DK; Song Y; Baek MS; Sawa Y; Singh G; Taylor B; Rubio-Mills A; Flanagan JL; Wiener-Kronish JP; Lynch SV
    J Bacteriol; 2007 Mar; 189(6):2203-9. PubMed ID: 17209027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.
    Jain M; Ramirez D; Seshadri R; Cullina JF; Powers CA; Schulert GS; Bar-Meir M; Sullivan CL; McColley SA; Hauser AR
    J Clin Microbiol; 2004 Nov; 42(11):5229-37. PubMed ID: 15528719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenesis and dynamic similarity in two regulatory networks in Pseudomonas aeruginosa.
    Guespin-Michel JF; Bernot G; Comet JP; Mérieau A; Richard A; Hulen C; Polack B
    Acta Biotheor; 2004; 52(4):379-90. PubMed ID: 15520540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Lee VT; Smith RS; Tümmler B; Lory S
    Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.
    Priebe GP; Dean CR; Zaidi T; Meluleni GJ; Coleman FT; Coutinho YS; Noto MJ; Urban TA; Pier GB; Goldberg JB
    Infect Immun; 2004 Jul; 72(7):4224-32. PubMed ID: 15213167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
    Zolfaghar I; Evans DJ; Ronaghi R; Fleiszig SM
    Infect Immun; 2006 Jul; 74(7):3880-9. PubMed ID: 16790760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa.
    Laskowski MA; Osborn E; Kazmierczak BI
    Mol Microbiol; 2004 Nov; 54(4):1090-103. PubMed ID: 15522089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice.
    Lorè NI; Iraqi FA; Bragonzi A
    BMC Genet; 2015 Aug; 16():106. PubMed ID: 26310945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis.
    von Götz F; Häussler S; Jordan D; Saravanamuthu SS; Wehmhöner D; Strüssmann A; Lauber J; Attree I; Buer J; Tümmler B; Steinmetz I
    J Bacteriol; 2004 Jun; 186(12):3837-47. PubMed ID: 15175297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
    Berthelot P; Attree I; Plésiat P; Chabert J; de Bentzmann S; Pozzetto B; Grattard F;
    J Infect Dis; 2003 Aug; 188(4):512-8. PubMed ID: 12898437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pseudomonas aeruginosa PA14 type III secretion system is expressed but not essential to virulence in the Caenorhabditis elegans-P. aeruginosa pathogenicity model.
    Wareham DW; Papakonstantinopoulou A; Curtis MA
    FEMS Microbiol Lett; 2005 Jan; 242(2):209-16. PubMed ID: 15621439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PsrA is a positive transcriptional regulator of the type III secretion system in Pseudomonas aeruginosa.
    Shen DK; Filopon D; Kuhn L; Polack B; Toussaint B
    Infect Immun; 2006 Feb; 74(2):1121-9. PubMed ID: 16428760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines.
    Stepińska M; Trafny EA
    Microb Pathog; 2008 May; 44(5):448-58. PubMed ID: 18221854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of a polyamine derivative inhibiting the expression of type III secretion system in Pseudomonas aeruginosa.
    Wang C; Liu X; Wang J; Zhou J; Cui Z; Zhang LH
    Sci Rep; 2016 Aug; 6():30949. PubMed ID: 27484745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of virulence-related genes of type III secretion system of Pseudomonas aeruginosa].
    Zhuo C; Wang LX; Xiao SN; Li HY; Qiu GX; Zhong NS
    Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):354-9. PubMed ID: 21162783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.
    Wareham DW; Curtis MA
    Int J Med Microbiol; 2007 Jul; 297(4):227-34. PubMed ID: 17412636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.